|
It was reported that on (b)(6) 2026, in accordance with the physician¿s orders, a single-use implantable drug delivery device with an indwelling cannula was used to administer an iv infusion to the patient.During use, it was discovered that the cannula hub had fractured and become loose.Use was immediately discontinued, and a new drug delivery device was used to treat the patient.
|
|
H11: section a through f - the information provided by bd represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.Each event reported to bd is evaluated and investigated in accordance with our complaint investigation procedures.The investigation process includes, but is not limited to, evaluation of the event details provided by the complaint facility, a review of complaint history, manufacturing records and risk document where applicable, and an evaluation of the subject device when available to identify potential contributing factors.The device has not been returned to the manufacturer for evaluation.
|